Small Stocks, Big Money™

Zomedica Corp. (NYSE American: ZOM) has unveiled its latest diagnostic tool, the Cortisol assay for equine serum, on the TRUFORMA® platform. This first-of-its-kind, point-of-care assay empowers equine veterinarians to make rapid, life-saving decisions. Traditionally, cortisol measurement required days for lab results, delaying critical treatment. Now, veterinarians can obtain results in minutes, crucial for managing the health of sick foals. The TRUFORMA platform addresses a $1.5 billion US market, and with recent CE mark approval, will be expanding into the European market with significant growth potential. The new cortisol assay will be available for order in July.

Biotricity Inc. (Nasdaq: BTCY) launched HeartSecure, a direct-to-consumer cardiac screening service offering instant, at-home results. Addressing the leading cause of death globally, HeartSecure eliminates long wait times for appointments and test results, making cardiac health more accessible and affordable. Dr. Waqaas Al-Siddiq, CEO of Biotricity, emphasizes the company's commitment to democratizing cardiac care through innovative solutions. HeartSecure is poised to transform heart health management, catering to the growing $250 billion home healthcare market, projected to reach $383 billion by 2028.

GreenPower Motor Company Inc. (Nasdaq GP) (TSXV: GP) delivered its first all-electric, zero-emission Type D BEAST school bus manufactured at its South Charleston, West Virginia plant to Kanawha County School District. This milestone follows the delivery of the first four Nano BEASTs from the facility last December. GreenPower's Vice President of Production, Wendell White, confirms the plant's readiness for full-scale production of BEAST and Nano BEAST buses to meet national demand. GreenPower has 37 BEASTs in production for West Virginia, slated for delivery by year-end.

LOBO EV Technologies (Nasdaq: LOBO) strengthened its relationship with a leading Brazilian electric mobility dealer after a successful on-site inspection of its Wuxi and Tianjin factories. The Brazilian dealer, impressed by LOBO’s production capabilities and product quality, plans to centralize manufacturing and procurement with LOBO to enhance efficiency and reduce costs. This partnership marks a significant step in LOBO’s growing market share in Latin America, aligning with the global shift towards sustainable transportation, projected to expand from $28 billion in 2023 to over $39 billion by 2028.